| Patent | Date |
|---|
Transdermal Propranolol Patch For Treatment Of Malignant Melanoma
App 20140294920 - Enscore; David J. | 2014-10-02 |
Polymerizable biodegradable polymers including carbonate or dioxanone linkages
Grant RE39,713 - Sawhney , et al. July 3, 2 | 2007-07-03 |
Bioadhesive drug delivery system with enhanced gastric retention
App 20050064027 - Jacob, Jules S. ; et al. | 2005-03-24 |
Nanoparticulate bioactive agents
App 20040220081 - Kreitz, Mark R. ; et al. | 2004-11-04 |
Method of treatment for premature rupture of membranes in pregnancy (PROM)
Grant 6,350,463 - Herman , et al. February 26, 2 | 2002-02-26 |
Polymerizable biodegradable polymers including carbonate or dioxanone linkages
Grant 6,177,095 - Sawhney , et al. January 23, 2 | 2001-01-23 |
Drug delivery devices and process of manufacture
Grant 6,174,545 - Enscore , et al. January 16, 2 | 2001-01-16 |
Subsaturated nicotine transdermal therapeutic system
Grant 6,165,497 - Osborne , et al. December 26, 2 | 2000-12-26 |
Polymerizable biodegradable polymers including carbonate or dioxanone linkages
Grant 6,083,524 - Sawhney , et al. July 4, 2 | 2000-07-04 |
Drug delivery devices and process of manufacture
Grant 6,007,837 - Enscore , et al. December 28, 1 | 1999-12-28 |
Injectable drug delivery system and method
Grant 5,783,205 - Berggren , et al. July 21, 1 | 1998-07-21 |
Method of administering nicotine transdermally
Grant 5,633,008 - Osborne , et al. May 27, 1 | 1997-05-27 |
Injectable drug delivery system and method
Grant 5,620,700 - Berggren , et al. April 15, 1 | 1997-04-15 |
Subsaturated transdermal therapeutic system having improved release characteristics
Grant 5,462,745 - Enscore , et al. * October 31, 1 | 1995-10-31 |
Subsaturated nicotine transdermal therapeutic system
Grant 5,364,630 - Osborne , et al. * November 15, 1 | 1994-11-15 |
Subsaturated transdermal therapeutic system having improved release characteristics
Grant 5,344,656 - Enscore , et al. * September 6, 1 | 1994-09-06 |
Subsaturated transdermal therapeutic system having improved release characteristics
Grant 5,342,623 - Enscore , et al. * August 30, 1 | 1994-08-30 |
Subsaturated nicotine transdermal therapeutic system
Grant 5,004,610 - Osborne , et al. April 2, 1 | 1991-04-02 |
Transdermal delivery device having a rate controlling adhesive
Grant 4,938,759 - Enscore , et al. July 3, 1 | 1990-07-03 |
Subsaturated transdermal therapeutic system having improved release characteristics
Grant 4,908,027 - Enscore , et al. March 13, 1 | 1990-03-13 |
Transdermal delivery of drugs from an aqueous reservoir
Grant 4,904,475 - Gale , et al. February 27, 1 | 1990-02-27 |
Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix
Grant 4,832,953 - Campbell , et al. May 23, 1 | 1989-05-23 |
Transdermal drug composition with dual permeation enhancers
Grant 4,820,720 - Sanders , et al. * April 11, 1 | 1989-04-11 |
Transdermal administration of progesterone, estradiol esters, and mixtures thereof
Grant 4,788,062 - Gale , et al. November 29, 1 | 1988-11-29 |
Transdermal drug delivery device with dual permeation enhancers
Grant 4,764,379 - Sanders , et al. August 16, 1 | 1988-08-16 |
Transdermal delivery of highly ionized fat insoluble drugs
Grant 4,645,502 - Gale , et al. February 24, 1 | 1987-02-24 |
Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
Grant 4,573,995 - Chen , et al. March 4, 1 | 1986-03-04 |
Matrix composition for transdermal therapeutic system
Grant 4,559,222 - Enscore , et al. December 17, 1 | 1985-12-17 |
| 